1. Catalog
  2. WCLC 2025 - Posters & ePosters
  3. PT1.09.01 Chemoradiotherapy Plus Tislelizumab in A ...
PT1.09.01 Chemoradiotherapy Plus Tislelizumab in Advanced or Metastatic NSCLC: A Prospective, Multicenter, Phase II Study
Back to course
Asset Subtitle
sheng lin
Meta Tag
Speaker sheng lin
Topic Metastatic Non-small Cell Lung Cancer – Local Therapies
Powered By